Andra AP fonden grew its stake in shares of West Pharmaceutical Services, Inc. (NYSE: WST) by 723.5%

EXTON, Pa., July 21, 2026 /PRNewswire/ -- On July 21, 2026, the Board of Directors of West Pharmaceu

WST heads into Q2 earnings with expectations for revenue and EPS growth, backed by demand for biolog

Besides Wall Street's top-and-bottom-line estimates for West Pharmaceutical (WST), review projection

Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either M

West Pharmaceutical (WST) possesses the right combination of the two key ingredients for a likely ea

West Pharmaceutical Services, Inc.  WST is well positioned for growth, backed by strong demand for H

https://www.sec.gov/ix?doc=/Archives/edgar/data/0000105770/000010577026000093/wst-20260714.htmThe te

McKesson, Cardinal, West Pharmaceutical, Align and Henry have been highlighted in this Industry Outl

BNP Paribas analyst Curtis Moiles initiates coverage on West Pharmaceutical Servs (NYSE:WST) with

Here, we highlight five dental supplies stocks, MCK, CAH, WST, ALGN and HSIC, which are well positio

Morgan Stanley analyst Kallum Titchmarsh maintains West Pharmaceutical Servs (NYSE:WST) with a Eq

West Pharmaceutical completes the SmartDose 3.5mL sale to AbbVie, sharpening its focus on higher-gro

I track a curated universe of 50 high-quality dividend growth stocks to identify opportune entry poi

Does West Pharmaceutical Services (WST) have what it takes to be a top stock pick for momentum inves

EXTON, Pa., July 7, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global le

Evercore ISI Group analyst Daniel Markowitz maintains West Pharmaceutical Servs (NYSE:WST) with a

WST has surged nearly 33% YTD as strong earnings, GLP-1 demand and biologics growth fuel momentum th

Keybanc analyst Paul Knight maintains West Pharmaceutical Servs (NYSE:WST) with a Overweight and

EXTON, Pa., July 1, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global le

Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Merit Me

Wall Street analysts upgraded AJG & BRC. See analyst rating changes & how they view BRC stoc

Barclays analyst Luke Sergott upgrades West Pharmaceutical Servs (NYSE:WST) from Equal-Weight to

Pre-Market Stock Futures: Futures are trading higher after the bulls tried to rally stocks on Monday

I track a curated universe of 50 high-quality dividend growth stocks to identify attractive entry po

West Pharmaceutical Services, Inc. (WST) Presents at 46th Annual William Blair Growth Stock Conferen

The Microsoft founder's foundation recently added this healthcare stock to its portfolio.

Stephens & Co. analyst Steven Etoch reiterates West Pharmaceutical Servs (NYSE:WST) with a Ov

West Pharmaceutical said on Monday it appointed former Thermo Fisher Scientific executive Michel ​La

Morgan Stanley analyst Kallum Titchmarsh maintains West Pharmaceutical Servs (NYSE:WST) with a Eq

Donald Trump disclosed up to $680,000 in Eli Lilly stock purchases as Medicare initiatives advanced

West Pharmaceutical disclosed a cyberattack that disrupted operations as analysts assess financial r

Barclays analyst Luke Sergott maintains West Pharmaceutical Servs (NYSE:WST) with a Equal-Weight

West Pharmaceutical beats Q1 estimates on strong GLP-1 demand, raises 2026 outlook, and authorizes $

U.S. stocks dipped as Iran-Hormuz tensions lifted oil, IBM and ServiceNow cratered, and defensive se

U.S. stocks were lower on Thursday, with the Dow Jones dropping over 200 points. Comcast's stron

WST: 16% | West Pharmaceutical Services shares are trading higher after the company reported better-

West Pharmaceutical Servs (NYSE:WST) is looking for Q2 Adj EPS of $2.05-$2.12 vs $2.00 analyst estim

West Pharmaceutical Servs (NYSE:WST) sees Q2 sales of $830.000 million-$850.000 million vs $818.537

Outlook for Full-Year and Second Quarter 2026Full-year 2026 net sales guidance increased to a range

West Pharmaceutical Servs (NYSE:WST) raises FY2026 GAAP EPS guidance from $7.79-$8.14 to $8.15-$8.50

West Pharmaceutical Servs (NYSE:WST) reported quarterly earnings of $2.13 per share which beat the a

Barclays analyst Luke Sergott maintains West Pharmaceutical Servs (NYSE:WST) with a Equal-Weight

U.S. stocks rose broadly on Tuesday as crude oil plunges over 10% on Trump's Iran end-of-war sig

West Pharmaceutical Services, Inc. (NYSE:WST) announced today that Eric M. Green has informed the Bo

On February 17, 2026, the Board of Directors authorized a new share repurchase program for the purch

Barclays analyst Luke Sergott maintains West Pharmaceutical Servs (NYSE:WST) with a Equal-Weight